Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease

BACKGROUND: Biological therapies have been introduced for the treatment of chronic inflammatory diseases including rheumatoid arthritis (RA) and Crohn's disease (CD). The efficacy of biologics differs from patient to patient. Moreover these therapies are rather expensive, therefore treatment of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Mesko, Bertalan, Poliska, Szilard, Váncsa, Andrea, Szekanecz, Zoltan, Palatka, Karoly, Hollo, Zsolt, Horvath, Attila, Steiner, Laszlo, Zahuczky, Gabor, Podani, Janos, Nagy, and Laszlo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2013
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4064310/
https://ncbi.nlm.nih.gov/pubmed/23809696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/gm463
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller